ClinicalTrials.Veeva

Menu

Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

S

Sanoculis

Status

Completed

Conditions

Open Angle Glaucoma

Treatments

Device: Minimally Invasive Micro Trabeculostomy

Study type

Observational

Funder types

Industry

Identifiers

NCT06612346
MMS-EEU-7

Details and patient eligibility

About

This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.

Enrollment

36 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Male or female ≥ 18 years to ≤ 85 years old
  2. Subject who underwent MINT, and surgery was performed not earlier than 18 months from enrollment

Trial design

36 participants in 1 patient group

MINT Surgery Cohort
Description:
Cohort that includes subjects that have undergone the MINT surgical procedure.
Treatment:
Device: Minimally Invasive Micro Trabeculostomy

Trial contacts and locations

1

Loading...

Central trial contact

Khan Lau, OD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems